Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Smith W and Saba N (2005) Crit. Rev. Oncol. Hematol. 55: 143–152.
Lotan R (1997) Cancer Metastasis Rev. 16: 349–356.
Sun SY et al. (2000) Clin. Cancer Res. 6: 1563–1573.
Armstrong JL et al. (2005) Br. J. Cancer. 92: 696–704.
Scheer M, Kuebler AC and Zoller JE (2004) Oncologie 27: 187–193.
Lu XP et al. (1997) Nat. Med. 3: 686–690.
Chun KH, Pfahl M and Lotan R (2005) Oncogene 24: 3669–3677.
Sun SY et al. (1999) Cancer Res. 59: 2829–2833.
Fridman JS and Lowe SW (2003) Oncogene 22: 9030–9040.
Wang S and El-Deiry WS (2004) Cancer Treat. Res. 119: 175–187.
Dimberg A and Oberg F (2003) Leuk Lymphoma 44: 1641–1650.
Philipp-Staheli J, Payne SR and Kemp CJ (2001) Exp. Cell. Res. 264: 148–168.
Fu M et al. (2004) Endocrinology 145: 5439–5447.
Lutz RJ (2000) Biochem. Soc. Trans. 28: 51–56.
Chun KH et al. (2003) Cancer Res. 63: 3826–3832.
Acknowledgements
This work was supported in part by USPHS Head and Neck Cancer SPORE grant P50 CA907007 and P30 CA16672-30 Cancer center Core grant from the NCI. We thank Dr. Magnus Pfahl (Maxacore, San Diego, CA) for the gift of MX3350-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chun, KH., Lotan, R. Higher potency of the synthetic retinoid MX3350-1 compared to the natural all-trans-retinoic acid in modulation of cell cycle and induction of apoptosis in head and neck squamous carcinoma cells. Cell Death Differ 13, 1830–1832 (2006). https://doi.org/10.1038/sj.cdd.4401917
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cdd.4401917
